Earlier this morning, Kellyanne Conway appeared on Bloomberg to discuss Trump's economic policies regarding everything from job creation to tax cuts, energy investment, infrastructure spending, Obamacare and China. Of course, she started by taking the opportunity to boast about the "Trump Effect" that has already resulted in manufacturing jobs coming back to the United States and record high-er stock prices.
"First of all, you already see the Trump effect. You see that manufacturing jobs are already coming back to the U.S., or staying here. Plans to build factories in Mexico, to ship jobs over the border there, take them away from hardworking Americans have stopped. That's the Trump effect."
"You see that the stock market loves that fact that he was elected. We've had record highs over a number of days."
After the brief commercial introduction, Conway addressed Trump's plans to "roll back corrosive regulations" that have suffocated job creation, lower taxes across the board and work with companies to develop America's energy resources "in a responsible and profitable way for all of us."
"His job creation plan includes a number of things. First of all, it's just rolling back some of these corrosive regulations. We hear from business owners and aspiring business owners daily that it's the regulatory framework that is suffocating them."
"In addition, he has a very ambitious, very doable tax relief plan. He will create 25 million jobs over 10 years and he will reduce taxes across the board. Middle class tax relief. Those who don't pay taxes will have relief as well."
"Also in there is energy investment. This is something that we just haven't had in the past 8 years. We've been pretty hostile as a nation toward energy investment. You know what is made in America, our energy sources. It's under our feet and it's off our shores. And it's time we have Presidential leadership that will help develop it in a responsible and profitable way for all of us."
Conway also took aim at the Pharma industry saying "to repeal and replace Obamacare without having a conversation about drug pricing seems like not a reasonable prospect."
More/Video
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.